Portable glucose sensors with an accurate and longterm stable in vivo function have been in demand for several decades because such devices are of strategic importance in the diagnosis and treatment of diabetes mellitus [1±3]. Despite remarkable progress, the development of new and improvement of existing prototypes is desirable.
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Abstract Aims/hypothesis. To provide a nonenzymatic sensor for glucose monitoring in subcutaneous tissue. Methods. A continuously working affinity sensor based on the glucose-dependent viscosity of a sensitive liquid containing dextran and concanavalin A has been designed by arranging a microdialysis probe, two flow-resisting capillaries and two pressure transducers in a linear flow system. It allows synchronous processing of the viscosity of the sensitive liquid at the standard glucose concentration and the glucose concentration to be measured. In preliminary human trials the sensor was implanted into the subcutaneous tissue of the forearm and its read-out was compared with capillary blood concentrations. Results. In vitro, the viscometric sensor shows a linear and long-term stable dependence on the glucose concentration without detectable drift. At the applied flow rate of the sensitive liquid (about 5 ml/h) the technical delay is 5 to 10 min. The read-out of the implanted sensor followed the dynamics of the capillary blood glucose concentrations with a time-shift of 10 to 15 min but showed a systematic error when based on precalibration with polymer-free glucose solutions. After appropriate in vivo calibration, the readout was in good or acceptable coincidence with capillary blood concentrations according to the error grid method and did not show any detectable reduction of sensitivity during the periods of measurement (up to 44 h). Conclusion/interpretion. The viscometric-affinity sensor is an efficient tool for current research on glucose monitoring in the subcutaneous tissue and can potentially be further developed for routine clinical use. [Diabetologia (2001) 
44: 416±423]
Keywords Concanavalin A, dextran, glucose monitoring, microdialysis probe, subcutaneous tissue, viscometric affinity sensor. permeable to glucose than to dissolved oxygen [13±16] . Adapting the sensing process to the microenvironment in the subcutaneous tissue was found to be difficult because implantation results in unforeseeable decreases in sensor sensitivity. Tissue-generated increases in diffusion resistances or the presence of electrochemically active solutes have been suggested as possible reasons [2, 8, 16, 17] .
Some of these difficulties have been overcome in the development of the GOD-microsensor supplied by Minimed (Sylmar, Calif., USA), which obtained a pre-market approval last year [18] . The application of this sensor requires individual and frequent calibrations on the basis of parallel capillary blood analysis and, therefore, further research on glucose monitoring in the subcutaneous tissue is important. One approach is the use of electrochemical GOD-microsensors in combination with microdialysis because sensors are more stable in the dialysate than in direct contact with tissue [19±22] .
Microdialysis also enables the construction of implantable glucose sensors based on a competitive affinity assay [20] . In the affinity sensors [23] , the carbohydrate binding protein concanavalin A (ConA), a lectin of plant origin, and its polymer glycoligand, dextran, are enclosed in an implantable dialysis fibre segment. Unlike the polymers, glucose can diffuse through the fibre membrane. Binding of ConA to dextran is reversibly weakened by glucose because the ConA-binding sites have an affinity to both the free sugar and the terminal glucose residues of the polysaccharide. The original prototype and further variants of the glucose-affinity sensor use optoelectronics to measure a glucose-dependent fluorescence signal created in the fibre lumen either by sorption/ desorption of fluorescence-labelled polymer molecules or by association-dependent fluorescence quenching [23±27] .
Viscometric affinity assays for glucose and related sensor concepts [28±30] use the high and glucose-dependent viscosity found in concentrated solutions of high-molecular-weight dextran and ConA. Saturating concentrations of free glucose reduce this viscosity by more than one order of magnitude [28] . By using a suitable reference measurement, the viscometric glucose assay is insensitive to variations in measuring conditions such as temperature and polymer concentration [31] . Although different concepts of viscometric sensors have been developed [29, 32±33] , applicable miniaturised prototypes for continuous measurement in the subcutaneous tissue have not been available before. We describe such a device and report on its function in vitro and in preliminary human trials.
Material and methods
Sensitive liquid. The sensitive liquid (SL) contained 7 % Dextran T2000 (Pharmacia, Uppsala, Sweden), 0.7 % concanavalin A (type IV, cat. no. C 2010, Sigma-Aldrich Chemie, Deisenhofen, Germany), 5 mmol/l d-glucose, 0.1 % phenol and 0.1 % mcresol. These substances were dissolved in a physiological saline solution. The pH was adjusted to 7.4.
Glucose solutions. Glucose solutions used for calibration and in vitro tests containted 130 mmol/l NaCl, 5 mmol/l KCl, 15 mmol/l NaN 3 , and 10 mmol/l TRIS-(hydroxmethyl)-aminomethane-hydrochloride at pH 7.4. Microdialysis fibre. The previously applied microdialysis fibre [30] with an inner diameter of 200 mm (Kunstseidewerk Pirna, Germany) was used. The membrane of this fibre consists of regenerated cellulose and is completely impermeable to molecules with a Stokes' radius greater than 2 nm (proteins with a molecular weight > 15,000 M r ) in long-term experiments [34] .
Viscometric sensor. The sensor measures the viscosity of the SL before and after its transfer through a dialysis fibre [32] . It includes a dialysis probe, flow-resisting capillaries and pressure transducers (Fig. 1) . The SL is continuously pumped with low rate (~5 ml/h) through the system. The pressure transducers P1 and P2 (AktivSensor GmbH, Stahnsdorf, Germany) measure the flow-mediated pressures before (p The proprietary implantable needle-like transdermal dialysis probe consists of two parallel steel cannulae (length 30 mm, outer diameter each 0.6 mm) with a sharpened tip. The inlet cannula is sealed at the tip and its lumen is connected with the dialysis fibre in the apical region. The outlet capillary surrounds the major part of the dialysis fibre segment. The membrane of the latter is exposed to the external liquid or the subcutaneous tissue at two parallel lateral windows of 11-mm length. At its outlet, the dialysis fibre segment is directly connected with the measuring capillary. The pressure transducers, the reference capillary, and a waste container are integrated into a flat rectangular box (13 35 47 mm, about 25 g). Flexible tubes connect this box with the dialysis probe and a modified H-Tron V100plus pump (Disetronic Medical Systems, Sulzbach, Germany), which supplies the sensor with a nearly constant and pulse-free flow (usually 5 ml/h) of fresh SL. A programmable data logger (TT5F, Onset Computer, Pocasset, Mass., USA) was used for signal transformation and storage as well as display of glucose concentrations and data download to a personal computer.
Transformation of the viscosity-related signals into glucose concentrations. The relative fluidity (F r ) of the sensitive liquid, which shows a linear dependence on the glucose concentration C [31] , is obtained from the signals given by pressure transducer 1 (p 1 ) and pressure transducer 2 (p m ) by:
wherein a represents a linearization coefficient, (p 1 ±p m ) is related to the viscosity of the SL at the reference glucose concentration (5 mmol/l) and p m to the viscosity of the SL at the measuring glucose concentration. Because flow resistances of the reference and measuring capillaries (R ref and R m ) were neither equal nor accurately defined, the appropriate value of a (enabling the maximum correlation coefficient of the linear regression between F r and the glucose concentration) had to be calculated for each combination of the measuring system and dialysis probe. To continuously display and register glucose concentrations the pressure signals that were actually measured were on-line transformed by the data logger to F r and the glucose concentration every 30 s. After read-out to the computer, stored values of six subsequent measurements were averaged by a macro in the Excel program to obtain means of 3-min intervals which were used for further evaluations and graphics.
Implantation of the dialysis probe and wearing of the viscometric affinity sensor (VAS). After disinfecting the skin surface with a Cutasept F spray (Bode Chemie, Hamburg, Germany), the precalibrated dialysis probe was implanted in the subcutaneous tissue of the left forearm (inner face) parallel to the skin's surface without interruption of the flow. The box with the pressure transducers was fixed on the skin by an adhesive tape. The pump was fastened by elastic ribbons to the forearm close to the measuring box and the logger was worn on the belt with the signal cable routed through the shirt sleeve. The system on the forearm was covered with an elastic wool tissue to prevent temperature fluctuations.
Calibration by capillary blood values. Stored pressure signals were transferred to the computer for a preliminary in vivo calibration on the basis of at least five measurements of capillary blood glucose concentrations (C cap ) obtained within about 3 h after an initial adaptation period of 0.5 to 1.5 h after implantation. Programming of the logger with the preliminary calibration parameters gave reliable values on the display during the experiment. For the more accurate retrospective calibration, the full set of measured capillary blood values at times t (C t cap ) was correlated with corresponding delayed F r values (F r t + t ) using different estimates of the time-shift t, and the best-fitting value (maximum correlation coefficient) was obtained by approximation. The linear regression obtained with this t value was used for calibration.
Results
Kinetics and stability of the sensor response. When the dialysis probe of the sensor was transferred from one glucose standard solution to the next (Fig. 2) , the read-out reached a new constant value within a time of 5 to 10 min. As the glucose value displayed is obtained by reference to the internal standard, it did not show any drift. At all tested concentrations the read-out was stable for at least 14 days, and its dependence on the glucose concentration within the physiologically interesting range is approximately linear (Fig. 2 ). An increase of the flow rate decreased the response time but did not reduce the sensor read-out, unless this rate exceeded 15 ml/h (data not shown). To ensure 100 % recovery in the subcutaneous tissue even when external diffusion resistance increased, a flow rate of approximately 5 ml/h was adjusted for in vivo and in vitro experiments.
Preliminary human trials. In self-tests carried out by some of the authors the dialysis probe was implanted into the subcutaneous tissue of the forearm and the sensor response was registered. No inflammatory reactions of the skin were observed. Generally the relative fluidity F r obtained by the sensor in the subcutaneous tissue varied in correlation with the measured capillary blood concentration (Table 1) but the glucose concentrations computed by parameters of in vitro calibration were significantly (a = 0.01) below the capillary blood glucose concentrations. Likewise, in blood plasma samples the glucose concentrations read out by the precalibrated sensor were lower than accurately predetermined values. In both cases, the mean difference is 2 to 3 mmol/l (Fig. 3) .
Because in vitro calibration was insufficient, the sensor read-out was based on a calibration by the capillary blood values as described in Material and methods. Results of all experiments carried out for measuring periods of more than 12 h are summarised in Table 1 . Subjects 1±3 (curves not shown) had normal dynamics of capillary blood values with a slight transient increase after the meals. Subject 4, a person with Type I (insulin-dependent) diabetes mellitus, provoked relatively large changes in the capillary blood sugar concentration by choice of diet and insulin dosage, which were well recorded by the calibrated sensor (Fig. 4) . The curve presented followed the capillary blood values with a best-fitting time shift of 13 min. Similar results were obtained in experiments with longer periods of measurement, when hyperglycaemic excursions occurred on the first and second day. As expected from the higher range of variation in the glucose concentrations, the correla- Pooled data of all experiments were analysed by the error grid method, which illustrates the therapeutic significance of differences between glucose concentrations obtained by the tested and the reference method [35] . Coincidence is good for 71.8 % and sufficient for 27.3 % of the values (Fig. 5, Table 1 ).
The delay t allowing the best-fit between the sensor read-out and the capillary blood concentration varied between 7 and 19 min. When the read-out was obtained by the standard procedure taking t into account, the coefficient of variation obtained with the pooled values (n = 256) is 0.13 ( Table 1) . As a result of retrospective calibration, the linear regression of the capillary blood glucose concentration and the coordinated sensor read-out (Figs. 4 and 5 ) coincides with the line of identity, and the mean of the differences (d) between the sensor read-out and this line [36] was set to zero. These differences varied with standard deviations of 0.63 to 1.34 mmol/l, when the delay was taken into account. Without consideration of t, the correlation coefficients were lower and the standard deviations were higher. Absolute differences (|d|) tended to rise with the glucose concentration (not significant with a probability of 95 %, data not shown).
When the deviation between the sensor read-out and the capillary blood concentration d was correlated with the measuring time, this did not result in a reproducible trend. The regression coefficient of the pooled values is ±0.003 mmol´l ±1´h±1 ; R 2 values obtained for single experiments are listed in Table 1 .
Discussion
The structure of the dialysis probe we describe protects the cellulose fibre from mechanical forces and allows simple implantation. It should be emphasised that the concept of the relative fluidity [31] has been straightforward for the design of the VAS, as it facilitates calibration and reduces the undesired influence of variations in temperature, air pressure, flow rate and polymer concentrations, all of which strongly affect the absolute measure of viscosity.
The functional properties of the dialysis probes and the measuring, units we tested were well reproducible. The in vitro experiments show that sensitivity, linearity range, response time, reproducibility and measuring stability of the VAS are suitable for glucose monitoring in the physiological system. Our self-testing is only preliminary to the necessary in vivo studies but the results are informative in so far as they show a stable functioning of the VAS in the subcutaneous tissue over 1±2 days. Neither a systematic drift nor a sensitivity change was found within the periods the in vivo application was studied.
The data shown are estimates of capillary blood concentrations obtained by the sensor function in the subcutaneous tissue rather than estimates of the real glucose concentration in the interstitial liquid be- All capillary blood measurements (C t cap ) which could be coordinated to a sensor read-out after an initial adaptation period of 0.5 to 1.5 h are included. The coordinated read-out of glucose concentrations C t+t is based on one retrospective calibration in each experiment cause they are based on calibration by the capillary blood values. The deviations we observed between the sensor read-out and capillary blood glucose concentrations include the combined errors of both measurements and possible fluctuations of the ratio between glucose concentrations in the capillary blood and the interstitial liquid.
We found that calibration with polymer-free glucose solutions is not sufficient for glucose sensing in the blood plasma and subcutaneous tissue because the read-out based on this calibration was lower than accurate values (plasma) or reasonable estimates (interstitial liquid). At low perfusion rates the colloidosmotic suction of external proteins has a relatively strong effect on the volume flux through the dialysis membrane [37] and this should decrease the readout by increasing the ConA concentration and viscosity in the measuring capillary. Addition of polyethylene glycol to standard glucose solutions in a concentration, which simulates the colloid-osmotic pressure of blood plasma (~3.4 kPa), causes a reduction of the sensor read-out, which is similar to that observed in the blood plasma (unpublished). In future, external calibration will be improved by the use of polymercontaining glucose standard solutions.
Although ConA-based affinity sensors are less sensitive and glucose-specific than GOD sensors, this is not relevant for the application in blood or the subcutaneous tissue, where glucose occurs at a relatively high concentration and is the only sugar species of the dialysate which can interact with the ConA complexes in the fibre lumen. Compared with the enzyme sensors, ConA-based sensors have common advantages: extremely high stability of the glucose receptor protein [30] , independence from oxygen pressure or electrode poisons, and the reversible character of the signal transformation process, which enables the equilibration of the sensing polymers with the glucose concentration of the matrix. The latter 27.10.1999) . A Time course of capillary blood glucose concentrations (points) and contemporary sensor read-out (line). Sensor read-out is based on one retrospective calibration by capillary blood values taking into account the best-fitting time shift (t = 13 min). The subject used the insulin pump H-TRONplus V100 (Disetronic Medical Systems, Sulzbach, Germany) with the insulin preparation H-Tronin 100 (Aventis Pharma Deutschland, Bad Soden, Germany). The pump was programmed to the subjects individual basal rate. Meals are indicated by M, additional amounts of insulin (IU) by numerals. At the 10th hour the subject ate without a preprandial insulin dosage. After reaching a capillary blood value of 15 mmol/l, the subject injected 12 IE of the rapidly absorbed insulin Humalog 100 (Lilly Deutschland, Bad Homburg, Germany). B Correlation of the glucose concentrations read out by the sensor at times t + 13 min with capillary blood concentration measured at times t Table 1 (n = 256) are included. For each experiment data were processed on the basis of one retrospective calibration using the best-fitting time shift. Fields A-E refer to the potential therapeutic significance of measuring errors. Provided the reference value is correct, appropriate action based on the sensor-readout would be acceptable, if results lay in field A (71.8 %) and B (27.3 %), but potentially dangerous, if they lay in fields C, D or E (0.9 %) A B point is especially important, as a constant diffusion resistance for glucose at the sensor surface (a prerequisite of constant sensitivity of the amperometric GOD sensors) seems to be difficult to realise in vivo [13, 16±17] .
In the VAS, the proper measuring element, a simple capillary flow resistor, is immediately connected with the dialysis fibre to allow a short response time at flow rates low enough for 100 % recovery [21] . This structure resembles that of a recently described GOD sensor, which combines ultrafiltration or microdialysis at low flow rate with the function of a closely coupled minute GOD-microelectrode [22] . A comparison of the in vivo function of both dialysistype sensors is not yet possible.
The delay in the in vitro sensor response (5±10 min) is larger than expected from the times necessary for sugar diffusion and volume flow through the measuring capillary (1±2 min at a flow rate of 5 ml/h). The delay is probably due to the elastic volume capacity of the liquid conductor between pressure transducer 2 and the measuring capillary because it is reduced with increasing flow rate and the primary response is a pressure change. This technical delay is possibly a component of the time-shift between changes of the capillary blood glucose concentration and sensor response found in vivo experiments and needs to be reduced by further improvements.
The requirement for a liquid flow carrying ConA, a non-human protein, in relatively high concentration through the dialysis probe must be considered as a technical complication (as in other microdialysis-devices) and is a risk because skin reactions might occur if the dialysis probe leaks. This risk has to be investigated carefully and leaks in the dialysis probe should be excluded rigorously before any clinical study with the VAS. The amount of ConA which can eventually come into contact with the physiological system is extremely small in technically more demanding variants of the VAS because in these variants the ConA solution is restricted to the dialysis fibre segment [32, 33] .
Comparison of the potential of the VAS with that of currently developed minimally-invasive GOD sensors [9, 18, 22] would be premature. Irrespective of a possible development of the VAS to a product for routine therapeutic use, the supply of a functioning transdermal sensor with an alternative measuring principle is undoubtedly of great interest for research in the field of wearable glucose sensors because it offers the possibility of an independent in situ reference.
